The Hôpital d'instruction des armées Percy or HIA Percy is a military hospital in Clamart, near Paris, France. It is managed by the Service de santé des armées and provides health services to both military and civilian patients. It is named after Pierre-François Percy, military surgeon during the Napoleonic wars.

During the past decade, Hôpital d'instruction des armées Percy conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 9 clinical trials were completed, i.e. on average, 12.9% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 7 clinical trials were completed. i.e. 17.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital d'instruction des armées Percy" #1 sponsor was "Direction Centrale du Service de Santé des Armées" with 13 trials, followed by "Acute Leukemia French Association" with 7 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 6 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 5 trials sponsored and "The Lymphoma Academic Research Organisation" with 5 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital d'instruction des armées Percy" #1 collaborator was "Assistance Publique - Hôpitaux de Paris" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Celgene Corporation" with 3 trials as a collaborator, "Intergroupe Francophone du Myelome" with 3 trials as a collaborator and "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator. Other collaborators include 81 different institutions and companies that were collaborators in the rest 86 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital d'instruction des armées Percy" are "Acute Myeloid Leukemia" (12 trials), "Multiple Myeloma" (6 trials), "Myeloma" (3 trials), "Acute Myeloid Leukemia (AML)" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Hôpital d'instruction des armées Percy" in a lesser frequency.

Most popular intervention types in "Hôpital d'instruction des armées Percy" are "Drug" (62 trials), "Other" (20 trials), "Device" (12 trials), "Procedure" (7 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Dexamethasone" (3 trials), "ABVD regimen" (2 trials), "BEACOPP regimen" (2 trials) and "Blood collection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital d'instruction des armées Percy" are 106 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hôpital d'instruction des armées Percy". 4 are not yet recruiting, 29 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Hôpital d'instruction des armées Percy, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital d'instruction des armées Percy, 3 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 12 trials that are defined as “Not Applicable".